NCT06905977

Brief Summary

To follow up cases of thick cornea with high back elevation by pentacam.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
1mo left

Started May 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
May 2025Jun 2026

First Submitted

Initial submission to the registry

March 14, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

April 2, 2025

Completed
29 days until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

April 2, 2025

Status Verified

March 1, 2025

Enrollment Period

1 year

First QC Date

March 14, 2025

Last Update Submit

March 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Measurement of corneal thickness and back corneal elevation by pentacam device

    The investigator will image the cornea to measure corneal thickness and back corneal elevation using the Pentacam device and follow up for cases of thick corneas with high back elevation at 3 months, 6 months, and 1 year.

    Baseline

Interventions

pentacamDEVICE

we will follow up on cases of thick cornea with high back elevation

Eligibility Criteria

Age6 Years+
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

any age can interact with pentacam device

You may qualify if:

  • Any patient can interact with pentacam. Both Genders: include both males and females. Patients with thick cornea (\>540 µm) with high back elevation.

You may not qualify if:

  • Patients with any eye disease (significant cataract or unstable glaucoma)
  • Uncontrolled external disease such as blepharitis , moderate to severe dry eye and allergy.
  • Patient with ocular disease such as uveitis, post herpetic infection and corneal opacity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

March 14, 2025

First Posted

April 2, 2025

Study Start

May 1, 2025

Primary Completion

May 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

April 2, 2025

Record last verified: 2025-03